These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease. Esmaeili Tazangi P; Moosavi SM; Shabani M; Haghani M Pharmacol Biochem Behav; 2015 Mar; 130():15-21. PubMed ID: 25553822 [TBL] [Abstract][Full Text] [Related]
24. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation. Bisel BE; Henkins KM; Parfitt KD Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011 [TBL] [Abstract][Full Text] [Related]
25. Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric Aβ42: an early index of Alzheimer's disease. Koppensteiner P; Trinchese F; Fà M; Puzzo D; Gulisano W; Yan S; Poussin A; Liu S; Orozco I; Dale E; Teich AF; Palmeri A; Ninan I; Boehm S; Arancio O Sci Rep; 2016 Sep; 6():32553. PubMed ID: 27581852 [TBL] [Abstract][Full Text] [Related]
26. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo. Jing W; Guo F; Cheng L; Zhang JF; Qi JS Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464 [TBL] [Abstract][Full Text] [Related]
27. Susceptibility to Aβo and TBOA of LTD and Extrasynaptic NMDAR-Dependent Tonic Current in the Aged Rat Hippocampus. Dutar P; Potier B Neurochem Res; 2019 Mar; 44(3):692-702. PubMed ID: 30426348 [TBL] [Abstract][Full Text] [Related]
28. Long-term depression links amyloid-β to the pathological hyperphosphorylation of tau. Taylor HBC; Emptage NJ; Jeans AF Cell Rep; 2021 Aug; 36(9):109638. PubMed ID: 34469725 [TBL] [Abstract][Full Text] [Related]
29. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades. Matos M; Augusto E; Oliveira CR; Agostinho P Neuroscience; 2008 Oct; 156(4):898-910. PubMed ID: 18790019 [TBL] [Abstract][Full Text] [Related]
30. Selective impairment of some forms of synaptic plasticity by oligomeric amyloid-β peptide in the mouse hippocampus: implication of extrasynaptic NMDA receptors. Kervern M; Angeli A; Nicole O; Léveillé F; Parent B; Villette V; Buisson A; Dutar P J Alzheimers Dis; 2012; 32(1):183-96. PubMed ID: 22785392 [TBL] [Abstract][Full Text] [Related]
32. Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. Puzzo D; Privitera L; Leznik E; Fà M; Staniszewski A; Palmeri A; Arancio O J Neurosci; 2008 Dec; 28(53):14537-45. PubMed ID: 19118188 [TBL] [Abstract][Full Text] [Related]
33. Protective cap over CA1 synapses: extrasynaptic glutamate does not reach the postsynaptic density. Lozovaya N; Melnik S; Tsintsadze T; Grebenyuk S; Kirichok Y; Krishtal O Brain Res; 2004 Jun; 1011(2):195-205. PubMed ID: 15157806 [TBL] [Abstract][Full Text] [Related]
34. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats. Cai HY; Hölscher C; Yue XH; Zhang SX; Wang XH; Qiao F; Yang W; Qi JS Neuroscience; 2014 Sep; 277():6-13. PubMed ID: 24583037 [TBL] [Abstract][Full Text] [Related]
35. N-methyl-D-aspartate receptor-dependent long-term potentiation in CA1 region affects synaptic expression of glutamate receptor subunits and associated proteins in the whole hippocampus. Zhong WX; Dong ZF; Tian M; Cao J; Xu L; Luo JH Neuroscience; 2006 Sep; 141(3):1399-413. PubMed ID: 16766131 [TBL] [Abstract][Full Text] [Related]
36. Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo. Hu NW; Smith IM; Walsh DM; Rowan MJ Brain; 2008 Sep; 131(Pt 9):2414-24. PubMed ID: 18678563 [TBL] [Abstract][Full Text] [Related]
37. Amyloid beta peptides and glutamatergic synaptic dysregulation. Parameshwaran K; Dhanasekaran M; Suppiramaniam V Exp Neurol; 2008 Mar; 210(1):7-13. PubMed ID: 18053990 [TBL] [Abstract][Full Text] [Related]
38. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease. Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830 [TBL] [Abstract][Full Text] [Related]
39. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709 [TBL] [Abstract][Full Text] [Related]